Remove 2013 Remove Blogging Remove Pricing Remove San Diego
article thumbnail

Brain Corp.’s First Product is a Brain for Floor-Scrubbing Machines

Xconomy

Headed by the computational neuroscientist Eugene Izhikevich, the company maintained a low profile at Qualcomm’s San Diego headquarters until 2013, when Brain Corp. The company actually has been test-driving its technology on floor scrubbers used to clean Jimbo’s, a San Diego natural foods grocer. “We

Product 106
article thumbnail

Despite Low Crop Prices, Corporate and VC Agtech Investments Soar

Xconomy

Prices for agricultural commodities such as corn, soy, and wheat are at their lowest levels in years, but investment in agricultural technology has never been better. The increase in dollars flowing to agtech comes despite commodity prices that are down 65 percent from their 2013 peak, the report says.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

As Drone Navigation Advances, SlantRange Focuses on Farm Analytics

Xconomy

— 5D Robotics , founded in 2009 in Carlsbad, CA, (about 30 miles north of San Diego), has developed a device that integrates GPS, inertial guidance, optical positioning, and other technologies. SlantRange, a San Diego company founded almost three years ago, is a drone-related startup already generating sales.

article thumbnail

TerrAvion’s Eye in the Sky For Growers, And Now, Ranchers

Xconomy

Morris did go on to co-found an aerial imagery company for agriculture in 2013, but he scrapped the idea of using drones. It’s the same performance at one-twentieth the price,” Morris says. In spite of the “drone hype” in recent years, he turned to a much more established technology to get his imaging sensors aloft: small planes.

San Diego 107
article thumbnail

On Front Lines Of Price Dispute, Eye Doctors Wary of New Drug Data

Xconomy

They’re also a controversial part of the national debate over high drug prices, and their increased use has put ophthalmologists in the crosshairs of insurers, the federal government, and the press. Drugs that treat a form of vision loss known as age related macular degeneration aren’t just big business.

Pricing 40
article thumbnail

Bio Roundup: RIP Roger Tsien, Novartis CAR-T Wheel, Zika News & More

Xconomy

Nobel Prize winner Roger Tsien, a UC San Diego chemist, passed away in Oregon this week. As the San Diego Union Tribune reported in 2013, Tsien (pictured) was also unafraid to shine the spotlight on what he considered suspect scientific approaches, even when espoused by legends like DNA co-discoverer James Watson. .

News 57
article thumbnail

Audentes Prices $75M IPO As Gene Therapy Eyes First U.S. Approval

Xconomy

NASDAQ: AGTC ), AveXis (NASDAQ: AVXS ) and others have all gone public since 2013. Here’s more on Audentes shortly after its Series A round in 2013. Bluebird, Spark, UniQure (NASDAQ: QURE ), Dimension Therapeutics (NASDAQ: DMTX ), RegenXBio (NASDAQ: RGNX ), Voyager Therapeutics (NASDAQ: VYGR ), Applied Genetic Technologies Corp.

Pricing 40